CYP3A4内含子10对CYP3A4基因表达的增强子作用
The Enhancer Role of CYP3A4 Intron 10 in CYP3A4 Gene Expression
-
摘要: 目的 探讨CYP3A4内含子10及其内SNP CYP3A4*1G对CYP3A4基因表达的调控作用.方法构建CYP3A4启动子启动转录的CYP3A4真核表达质粒, 将CYP3A4内含子10 (CYP3A4*1G野生型/突变型) 正向或反向插入该质粒的启动子上游, 从而构建出不同基因型、不同方向的CYP3A4内含子10调控的CYP3A4真核表达质粒.将构建好的各质粒分别转染入Hep G2细胞, 应用实时荧光定量PCR方法检测CYP3A4 m RNA表达水平.结果 构建的重组质粒经酶切验证与测序鉴定, 插入片段的序列和方向与预期完全一致.无论CYP3A4*1G野生型还是突变型, 反向组CYP3A4 m RNA表达水平均高于正向组 (P<0.01) ;而CYP3A4内含子10无论是正向还是反向, CYP3A4*1G野生型组CYP3A4 m RNA表达水平均高于突变型组 (P<0.01) .此外, 正向突变组CYP3A4 m RNA表达水平低于阳性对照组, 不但没有增强CYP3A4启动子的转录作用反而有所减弱.结论CYP3A4内含子10有类似于增强子的功能, 能够影响CYP3A4启动子对CYP3A4基因的转录, 且具有方向性和CYP3A4*1G等位基因依赖性.Abstract: Objective To explore the regulation of CYP3A4 gene expression by CYP3A4 intron 10 and CYP3A4*1G.Methods CYP3A4 eukaryotic expression vector which promoted by CYP3A4 promoter was constructed.The forward and reverse full-length segments of CYP3A4 intron 10 (with CYP3A4*1G allele wild/mutant type) were ligated into the recombinant eukaryotic expression vector above at upstream of CYP3A4 promoter to construct CYP3A4 eukaryotic expression vector which promoted by CYP3A4 promoter and regulated by CYP3A4 intron 10 with different genotypes and directions.The vectors were transfected into Hep G2 respectively.The levels of CYP3A4 m RNA were detected by quantitative real-time PC.Results These insertion sequences and their directions were exactly correct.The expression level of CYP3A4 m RNA was higher when CYP3A4 intron 10 was inthe forward than in the reverse direction (P<0.01) ;the wild group showed higher CYP3A4 m RNA level than the mutant group (P<0.01) ;while the forward mutant group showed lower CYP3A4 m RNA level than the positive control group.Conclusion CYP3A4 intron 10 is like an enhancer functionally, which could influence the transcription of CYP3A4 promoter depending on its direction and regulation by CYP3A4*1G allele.
-
Key words:
- Intron /
- CYP3A4*1G /
- Eukaryotic expression vector
-
[1] [1]WANG D, GUO Y, WRIGHTON S A, et al.Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs[J].Pharmacogenomics, 2011, 11 (4) :274-286. [2] [2]DROGEMOLLER B, PLUMMER M, KORKIE L, et al.Characterization of the genetic variation present in CYP3A4in three South African populations[J].Frontiers in genetics, 2013, 4 (17) :1-17. [3] [3]GAO Y, ZHANG L R, FU Q.CYP3A4*1G polymorphism is associated with lipid-lowering efficacy of atorvastatin but not of simvastatin[J].European Journal of Clinical Pharmacology, 2008, 64 (9) :877-882. [4] [4]ZHANG W, CHANG Y Z, KAN Q C, et al.CYP3A4*1G genetic polymorphism influences CYP3A activity and response to fentanyl in Chinese gynecologic patients[J].European Journal Of Clinical Pharmacology, 2010, 66 (1) :61-66. [5] [5]HE B X, SHI L, QIU J, et al.The effect of CYP3A4*1G allele on the pharmacokinetics of atorvastatin in Chinese Han patients with coronary heart disease[J].Journal of Clinical Pharmacology, 2014, 54 (4) :462-467. [6] [6]YUAN J J, HOU J K, ZHANG W, et al.CYP3A4*1G Genetic Polymorphism Influences Metabolism of Fentanyl in Human Liver Microsomes in Chinese Patients[J].Pharmacology, 2015, 96 (1-2) :55-60. [7] [7]MIURA M, SATOH S, KAGAYA H, et al.Impact of the CYP3A4*1G polymorphism and its combination with CYP3A5 genotypes on tacrolimus pharmacokinetics in renal transplant patients[J].Pharmacogenomics, 2011, 12 (7) :977-984. [8]石伟龙, 唐惠林, 翟所迪.CYP3A4*1G基因多态性对肾移植受者他克莫司给药剂量及血药浓度影响的系统评价[J].中国临床药理学杂志, 2015, 31 (04) :292-296. [9] [9]YANG W H, ZHAO D Z, HAN S N, et al.CYP3A4*1G regulates CYP3A4 intron 10 enhancer and promoter activity in an allelic-dependent manner[J].International Journal of Clinical Pharmacology and Therapeutics, 2015, 53 (8) :647-657. [10]赵云龙, 杨卫红, 闫良, 等.CYP3A4*1G依赖的CYP3A4内含子10启动的真核表达载体的构建[J].郑州大学学报 (医学版) , 2016, 51 (2) :153-157. [11] [11]CHATTERJEE S, MIN L, KARUTURI R K, et al.The role of post-transcriptional RNA processing and plasmid vector sequences on transient transgene expression in zebrafish[J].Transgenic Research, 2010, 19 (2) :299-304. [12] [12]ROSE A B.Intron-Mediated Regulation of Gene Expression[M].Current Topics in Microbiology and Immunology, 2008, 326 (6) :277-290. [13] [13]PAN Y Y, CHEN R, ZHU L, et al.Utilizing modified ubi1introns to enhance exogenous gene expression in maize (Zea mays L.) and rice (Oryza sativa L.) [J].Journal of Integrative Agriculture, 2016, 15 (8) :1716-1726. [14] [14]DE LA TORRE C M, FINER J J.The intron and 5’distal region of the soybean Gmubi promoter contribute to very high levels of gene expression in transiently and stably transformed tissues[J].Plant Cell Reports, 2015, 34 (1) :111-120. [15] [15]CHOKAS A L, BICKFORD J S, BARILOVITS S J, et al.A TEAD1/p65 complex regulates the eutherian-conserved Mn SOD intronic enhancer, e RNA transcription and the innate immune response[J].Biochimica et Biophysica Acta, 2014, 1839 (11) :1205-1216. [16] [16]POUND L D, HANG Y, SARKAR S A, et al.The pancreatic isletβ-cell-enriched transcription factor Pdx-1 regulates Slc30a8gene transcription through an intronic enhancer[J].Biochemical Journal, 2011, 433 (1) :95-105. [17] [17]KRIZEK B A.Intronic sequences are required for AINTEGUMENTA-LIKE6 expression in Arabidopsis flowers[J].BMC Res Notes, 2015, 8 (556) :1-9. [18] [18]SRIBUDIANI Y, METZGER M, OSINGA J, et al.Variants in RET associated with Hirschsprung's disease affect binding of transcription factors and gene expression[J].Gastroenterology, 2011, 140 (2) :572-582. [19] [19]OGURA Y, KOU I, MIURA S, et al.A Functional SNP in BNC2 Is Associated with Adolescent Idiopathic Scoliosis[J].Am J Hum Genet, 2015, 97 (2) :337-342. [20] [20]CAVALLI M, PAN GANG, NORD H, et al.Looking beyond GWAS:allele-specific transcription factor binding drives the association of GALNT2 to HDL-C plasma levels[J].Lipids Health Dis, 2016, 15 (18) :1-5. [21] [21]VISSER M, PALSTRA R J, KAYSER M.Allele-specific transcriptional regulation of IRF4 in melanocytes is mediated by chromatin looping of the intronic rs12203592 enhancer to the IRF4 promoter[J].Hum Mol Genet, 2015, 24 (9) :2649-2661.
点击查看大图
计量
- 文章访问数: 1640
- HTML全文浏览量: 593
- PDF下载量: 157
- 被引次数: 0